Jul 07, 2021 8:00am EDT 180 Life Sciences Expands Scientific Fibrosis Platform with Collagen VI as a Driver and Disease Biomarker in Human Fibrosis Published in the FEBS Journal
Jun 28, 2021 8:00am EDT 180 Life Sciences Files Plan with Nasdaq Related to Delayed Quarterly Report on Form 10-Q and Form 10-K
Jun 10, 2021 9:12am EDT 180 Life Sciences Corp. Announces the Appointment of Pamela Marrone, PhD and Frank Knuettel II, MBA to Board of Directors
May 28, 2021 8:00am EDT 180 Life Sciences Corp. Announces the Appointment of Russell T. Ray, MBA and Teresa DeLuca MD, MBA to Board of Directors
May 21, 2021 4:45pm EDT 180 Life Sciences Corp. Receives Expected Notification From Nasdaq Related To Delayed Quarterly Report on Form 10-Q
Apr 20, 2021 8:00am EDT 180 Life Sciences Corp. Announces Collection of All Patient Data for Phase 2b Dupuytren’s Disease Trial
Apr 19, 2021 5:00pm EDT 180 Life Sciences Corp. Receives Expected Notification From Nasdaq Related To Delayed Annual Report on Form 10-K
Apr 14, 2021 8:15am EDT 180 Life Sciences Corp. Congratulates Dr. Lynn Williams on International Dupuytren Award 2021